The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial Hypertension

CompletedOBSERVATIONAL
Enrollment

5,448

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Hypertension
Interventions
DRUG

Pritor (Telmisartan , BAY68-9291)

Primary care hypertensive patients starting the therapy with Telmisartan

Trial Locations (4)

Unknown

Many Locations

Many Locations

Many Locations

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY